Philip H. Iffland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Philip H. Iffland has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Peter B. Crino
Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA
1 shared publication
Latest Publications
- 24 January 2017
- Published by Annual Reviews in Annual Review of Pathology: Mechanisms of Disease
- Vol. 12 (1) , 547-571
Focal Cortical Dysplasia: Gene Mutations, Cell Signaling, and Therapeutic Implications
Focal cortical dysplasias (FCDs) are malformations of cortical development (MCDs) that are highly associated with medication-resistant epilepsy and are the most common cause of neocortical epilepsy in children. FCDs are a heterogeneous group of developmental disorders caused by germline or somatic mutations that occur in genes regulating the PI3K/Akt/mTOR pathway—a key pathway in neuronal growth and migration. Accordingly, FCDs are characterized by abnormal cortical lamination, cell morphology (e.g., cytomegaly), and cellular polarity. In some FCD subtypes, balloon cells express proteins typically seen in neuroglial progenitor cells. Because recurrent intractable seizures are a common feature of FCDs, epileptogenic electrophysiological properties are also observed in addition to local inflammation. Here, we will summarize the current literature regarding FCDs, addressing the current classification system, histopathology, molecular genetics, electrophysiology, and transcriptome and cell signaling changes.
- 24 January 2017
- Published by Annual Reviews in Annual Review of Pathology: Mechanisms of Disease
- Vol. 12 (1) , 547-571
Focal Cortical Dysplasia: Gene Mutations, Cell Signaling, and Therapeutic Implications
Focal cortical dysplasias (FCDs) are malformations of cortical development (MCDs) that are highly associated with medication-resistant epilepsy and are the most common cause of neocortical epilepsy in children. FCDs are a heterogeneous group of developmental disorders caused by germline or somatic mutations that occur in genes regulating the PI3K/Akt/mTOR pathway—a key pathway in neuronal growth and migration. Accordingly, FCDs are characterized by abnormal cortical lamination, cell morphology (e.g., cytomegaly), and cellular polarity. In some FCD subtypes, balloon cells express proteins typically seen in neuroglial progenitor cells. Because recurrent intractable seizures are a common feature of FCDs, epileptogenic electrophysiological properties are also observed in addition to local inflammation. Here, we will summarize the current literature regarding FCDs, addressing the current classification system, histopathology, molecular genetics, electrophysiology, and transcriptome and cell signaling changes.